Uncategorized

18 Jul: LSO’S RESPONSE TO PMPRB INTERIM GUIDELINES CONSULATION

All stakeholders have a role in ensuring Canada can attract research and new medicine launches as we rebuild from the pandemic. In this context, LSO has provided a number of general recommendations and considerations to help guide the PMPRB’s approach for its interim guidelines period and beyond. Read LSO’s submission…

04 Jul: LSO is Hiring – External Affairs Manager

External Affairs Manager Operations – downtown Toronto, Ontario Make a difference with Life Sciences Ontario (LSO)  www.lifesciencesontario.ca Who we are and what we do: Life Sciences Ontario is a member-driven organization that represents and promotes the province’s vibrant and diverse life sciences sector. LSO collaborates with governments, academia, industry, and…

25 May: MOU established between Bioenterprise Canada and Life Sciences Ontario

Guelph/Toronto, 25 May 2022 – Ontario’s life sciences sector and Canada’s Food & Agri-Tech Engine have agreed to collaborate in support of innovation by signing a Memorandum of Understanding (MOU). Life Sciences Ontario, which represents Ontario’s pharmaceutical, medical device, agri-food and agri-tech, biotech and medicinal cannabis industries, has joined Bioenterprise Canada as a Knowledge…

20 May: Life Sciences Ontario calls on federal government to delay and reconsider federal price controls as all Canadians focus on COVID efforts

Canada and Ontario’s life sciences sector has been leading unprecedented efforts to respond to the COVID-19 crisis. However, our sector faces an impending challenge – the planned implementation of the Government of Canada’s amendments to the Patented Medicines Regulations. These new regulations threaten to divert our sector’s attention and resources away from…